Inherited Retinal Disease Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Inherited Retinal Disease Market Size Likely To Evolve From 2025 Through 2034?

The inherited retinal disease market size has experienced substantial growth in recent years. This market is projected to expand from $11.56 billion in 2024 to $12.54 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.5%. The expansion witnessed in the past can be attributed to several factors, including the increasing adoption of gene therapy, supportive regulatory incentives, the expansion of patient registries, a rise in clinical trials, and the development of patient-centric solutions.

The market size for inherited retinal diseases is projected to experience robust expansion over the coming years. This market is anticipated to reach $17.26 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this growth during the projected period include the rising application of CRISPR technology, the development of personalized treatment options, an emphasis on regenerative medicine, the expansion of patient advocacy efforts, and a concerted focus on enhancing patients’ quality of life. Key trends expected during this forecast timeframe encompass progress in optogenetics technology, the creation of artificial retina implants, the broadening of digital health platforms, the incorporation of artificial intelligence into disease modeling, and its utilization in treatment planning.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp

What Are The Key Drivers Of Growth In The Inherited Retinal Disease Market?

The rising prevalence of macular degeneration is projected to drive the growth of the inherited retinal disease market moving forward. Macular degeneration is an age-related eye condition that harms the macula, resulting in central vision loss and challenges with activities such as reading or recognizing faces. The growing incidence of macular degeneration is fueled by aging populations, longer life expectancy, and lifestyle factors like smoking and inadequate nutrition, which increase the risk. Inherited retinal disease treatment assists macular degeneration patients by addressing the underlying genetic causes of retinal degeneration, providing therapies that slow disease progression, recover lost vision, or even prevent further damage to the retina, ultimately enhancing visual outcomes and quality of life for individuals affected by age-related or inherited forms of macular degeneration. For instance, in February 2024, according to the Canadian Ophthalmological Society, a Canada-based nonprofit organization, it was reported that 2.5 million people in Canada aged over 55 lose their vision due to age-related macular degeneration (AMD). Consequently, the increasing prevalence of macular degeneration is propelling the expansion of the inherited retinal disease market.

What Are The Major Segments Identified In The Inherited Retinal Disease Market?

The inherited retinal diseasemarket covered in this report is segmented –

1) By Type: Diagnosis; Therapy

2) By Disease Type: Retinitis Pigmentosa; Choroideremia; Stargardt Disease; Cone-rode Dystrophy; Leber Congenital Amaurosis; Other Diseases

3) By Distribution Channel: Retail Sales; Direct Tender

4) By End Users: Hospitals; Speciality Clinics; Ambulatory Surgical Centres; Home Healthcare; Other End Users

Subsegments:

1) By Diagnosis: Genetic Testing (Genetic Screening); Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)); Electrophysiological Testing (Electroretinography); Visual Field Testing; Fundus Autofluorescence Imaging

2) By Therapy: Gene Therapy; Stem Cell Therapy; Retinal Prosthesis (Artificial Retina); Pharmacological Therapy (Gene Editing, Retinal Drugs); Photoreceptor Rescue Therapy

What Are The Latest Industry Trends Transforming The Inherited Retinal Disease Market?

Leading companies operating within the inherited retinal diseases market are prioritizing the development of innovative therapies, such as mutation-agnostic gene therapy, to offer more inclusive treatment options and address a wider array of genetic variations linked to these conditions. Mutation-agnostic gene therapy constitutes a treatment method that targets broader genetic mechanisms or pathways, rather than specific mutations, making it applicable to various genetic disorders. For instance, in March 2024, Nanoscope Therapeutics Inc, a US-based biotechnology company, announced positive results from a clinical trial of its lead program, MCO-010, which demonstrated vision improvements for patients experiencing permanent and severe vision loss from advanced retinitis pigmentosa. MCO-010 achieved its primary and key secondary endpoints with statistical significance and reported no serious adverse events.

Which Major Industry Participants Are Leading The Inherited Retinal Disease Market Growth?

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

Which Region Currently Holds The Largest Share Of The Inherited Retinal Disease Market?

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Inherited Retinal Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp

Browse Through More Reports Similar to the Global Inherited Retinal Disease Market 2025, By The Business Research Company

Vitreoretinal Surgery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vitreoretinal-surgery-devices-global-market-report

Retinal Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Retinal Disorder Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795